Alnylam Pharmaceuticals

Scientist, DMPK

Alnylam Pharmaceuticals$110K — $165K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • Ph.D. in relevant field or equivalent industry experience (Masters with 5+ years, Bachelors with 10+ years).
  • Strong foundation in quantitative pharmacology and PK/PD modeling.
  • Experience with data analysis techniques including non-compartmental and compartmental analysis.
  • Familiarity with PBPK, population PK, or mechanistic pharmacology modeling is a plus.
  • Proficiency in tools like Phoenix WinNonlin, Monolix, R for modeling and simulation.
  • Understanding of ADME principles and drug development processes, especially oligonucleotide therapeutics.
  • Demonstrated problem-solving abilities and adaptability.

Responsibilities

  • Design and execute in vitro and in vivo ADME and PK/PD studies to support DMPK strategy.
  • Employ quantitative pharmacology methods to characterize drug disposition and exposure-response relationships.
  • Integrate PK, PD, and biomarker data for candidate selection and dose projections.
  • Develop and validate models with tools like Phoenix WinNonlin, Monolix, and R.
  • Assist in designing preclinical studies for candidate progression through development.
  • Collaborate with cross-functional teams to analyze data and provide pharmacology insights.
  • Prepare well-documented reports and analyses for regulatory submissions.

Benefits

  • Comprehensive medical, dental, and vision coverage.
  • Life and disability insurance.
  • Flexible spending and health savings accounts.
  • 401(k) plan with generous company match.
  • Paid time off and wellness days.
  • Generous family resources and leave policies.
  • Company-wide recharge breaks to promote well-being.
Full Job Description
Overview

The mission of DMPK is to enable efficient and successful drug discovery and development of siRNA and other therapeutic candidates by characterizing and interpreting ADME (absorption, distribution, metabolism, and excretion) and PK/PD (pharmacokinetics/pharmacodynamics) relationships through quantitative pharmacology and modeling, consequently guiding candidate selection, human dose projection, and successful regulatory filings and interactions.

The ideal candidate will have a strong background in quantitative pharmacology, PK/PD modeling, and pharmacokinetic data analysis, a solid understanding of ADME and drug disposition, and exceptional problem-solving and communication skills to successfully collaborate with multiple project teams in a matrixed and fast-paced environment. This is an exciting opportunity to join a vibrant team and interact with highly motivated scientists across a broad array of disciplinary expertise areas.

This position is onsite and will be primarily located in Cambridge, MA.

Key Responsibilities

  • Support DMPK strategy across drug discovery and development by designing, executing, and interpreting in vitro and in vivo ADME and PK/PD studies for siRNA and other therapeutic modalities.
  • Apply quantitative pharmacology approaches-including non-compartmental analysis, compartmental PK/PD, PBPK, and mechanistic/systems modeling-to characterize drug disposition and exposure-response relationships.
  • Integrate PK, PD, and biomarker data to inform candidate selection, human dose projection, and first-in-human dose predictions.
  • Build, qualify, and clearly document models and simulations using tools such as Phoenix WinNonlin, Monolix, R, and other equivalent tools.
  • Contribute to the design of preclinical and translational studies that support progression of candidates from discovery through clinical development.
  • Collaborate with cross-functional project teams (bioanalysis, chemistry, biology, toxicology, and clinical pharmacology) to analyze data and communicate quantitative pharmacology insights.
  • Prepare clear, well-documented analyses, reports, and presentations, and contribute to regulatory submissions as needed.
  • Complete projects in a timely and clearly documented manner while maintaining high scientific and data-quality standards.
  • Stay current with emerging modeling methodologies and scientific literature to continuously strengthen the team's quantitative capabilities.


Qualifications

  • Ph.D. in pharmaceutical sciences, pharmacology, chemical or biomedical engineering, or a related quantitative discipline with 0+ years of relevant experience; or exceptional non-PhD (Masters degree with 5+ years, or Bachelors degree with 10+ years of relevant industry experience in DMPK or quantitative pharmacology.
  • Strong foundation in quantitative pharmacology and PK/PD modeling, with hands-on experience in non-compartmental and compartmental data analysis.
  • Exposure to PBPK, population PK, or systems/mechanistic pharmacology modeling is a strong plus.
  • Proficiency with modeling, simulation, and programming tools (e.g., Phoenix WinNonlin, Monolix, R).
  • Solid understanding of ADME principles and the drug discovery and development process; knowledge of oligonucleotide therapeutics (e.g., siRNA, ASO) or other novel modalities is a plus.
  • Demonstrates strong problem solving ability and adaptability, in and out of their comfort zone
  • Detail-oriented with exceptional organizational skills, and the ability to handle multiple projects, and thrive in a fast-paced, team-oriented environment
  • Has strong interpersonal skills to enable collaboration with cross-functional teams.

Possesses excellent verbal and written communication skills.

#LI-JR1

U.S. Pay Range

$110,400.00 - $165,600.00

The pay range reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam's robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a biotechnology company that focuses on RNA interference (RNAi) therapeutics. The company's products are designed to silence specific genes that cause diseases. Alnylam's pipeline includes products for the treatment of genetic, cardio-metabolic, and hepatic infectious diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Learn more about Alnylam Pharmaceuticals
Size
1,665 employees
Market Cap
$28.7 billion
Industry
Net Income
-$858.2 million
Founded
2002
5 Year Trend
+78.1%
Revenue
$492.8 million
NASDAQ

Similar Jobs

More Jobs at Alnylam Pharmaceuticals

More Pharmaceuticals & Biotech Jobs

Find similar Scientist, DMPK jobs: